Novartis India Ltd has decided to terminate its exclusive distribution and promotion agreement with Dr. Reddy’s Laboratories Ltd (DRL), bringing an end to a strategic partnership signed in 2022 for the marketing and sale of several established medicine brands in India. The company’s Board of Directors has approved the termination of the distribution and promotion […]